newsfilter
← Latest News
ACCESS Newswire·

NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. , a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus